News FDA approves Adstiladrin as first gene therapy for NMIBC The US Food and Drug Administration (FDA) has
News Regeneron, CytomX announce bispecific therapeutics for cance... Regeneron Pharmaceuticals, Inc. and CytomX Therapeutics, Inc.
News Support bot for cancer patient relatives wins WHO Health Hac... A bot that provides support to relatives of people with cancer – called Scally – has been named the winner of the World Hea
Views & Analysis At ESMO 2022, oncologists saw exciting cancer advances Lung, breast, and non-prostate genitourinary (NGU) cancer treatments were the most exciting tracks due to the march towards personalised medicine and expanded immunotherapy options.
Events Partner Content 6th Antifibrotic Drug Development Summit Only cross-disease, cross-organ fibrosis summit
News Agios mulls early FDA filing for sickle cell therapy Agios is planning to file its sickle cell disease candidate mitapivat with the FDA under the accelerated pathway within the next few months.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
